Evidence map›Paper›PMID 27622550›Full record

ArticlePloS one2016

The Antinociceptive Properties of the Corydalis yanhusuo Extract.

Lien Wang, Yan Zhang, Zhiwei Wang, Nian Gong, Tae Dong Kweon, Benjamin Vo, Chaoran Wang, Xiuli Zhang, Jae Yoon Chung, Amal Alachkar and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Large variability in the alkaloid content ofFrontiers in pharmacology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Uncovering the Effect and Mechanism ofFrontiers in pharmacology · 2022
    Article
  19. The Analgesic Properties ofMolecules (Basel, Switzerland) · 2021
    Review
  20. The Extract ofPharmaceuticals (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Lien WangDepartment of Pharmacology, University of California Irvine, Irvine, California, United States of America.
Yan ZhangDepartment of Pharmacology, University of California Irvine, Irvine, California, United States of America.
Zhiwei WangDepartment of Pharmacology, University of California Irvine, Irvine, California, United States of America.
Nian GongDepartment of Anesthesiology and Perioperative Care, University of California Irvine, Irvine, California, United States of America.
Tae Dong KweonDepartment of Anesthesiology and Perioperative Care, University of California Irvine, Irvine, California, United States of America.
Benjamin VoDepartment of Anesthesiology and Perioperative Care, University of California Irvine, Irvine, California, United States of America.
Chaoran WangDalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Liaoning, China.
Xiuli ZhangDalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Liaoning, China.
Jae Yoon ChungDepartment of Pharmacology, University of California Irvine, Irvine, California, United States of America.
Amal AlachkarDepartment of Pharmacology, University of California Irvine, Irvine, California, United States of America.
Xinmiao LiangDalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Liaoning, China.
David Z LuoDepartment of Anesthesiology and Perioperative Care, University of California Irvine, Irvine, California, United States of America.
Olivier CivelliDepartment of Pharmacology, University of California Irvine, Irvine, California, United States of America.
University of California, Irvine · USDalian Institute of Chemical Physics · CNChinese Academy of Sciences · CN

Funding

A novel neuropeptide system involved in drug abuseR01DA024746 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI CIVELLI, OLIVIER · 2010 to 2013
$1.5M
Hepatic Encephalopathy in Alcoholic Cirrhosis: A Systems Biology ApproachR01AA020203 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI BAJAJ, JASMOHAN S · 2010 to 2012
$1.0M
NIAAA NIH HHS R01 AA020203NIDA NIH HHS R01 DA024746
6 · The paper itself

Abstract

Corydalis yanhusuo. W.T. extracts (YHS) are widely used for the treatment of pain and inflammation. There are a few studies that assessed the effects of YHS in pain assays; however, none of these studies has systematically compared its activities in the different pain animal modes namely: acute, inflammatory and chronic pain. Furthermore, little is known about the mechanism of YHS activity in these assays. The aim of this study was to systematically evaluate the antinociceptive properties of YHS by testing it in four standardized pain assays and to investigate its mechanism. YHS antinociceptive properties were analyzed in the tail flick, the formalin paw licking, the von Frey filament and the hot box assays after spinal nerve ligation, which monitors acute nociceptive, persistent inflammatory and chronic neuropathic pain, respectively. YHS pharmacological profile was determined by screening it against a battery of G-protein coupled receptors and its mechanism of action was studied using knock-out mice. Our study shows that YHS, at a non-sedative dose, increases the tail flick latency in the tail flick assay without resulting in development of tolerance. YHS also decreases paw licking time in the formalin assay. Further, YHS increases paw withdraw threshold and latency in the von Frey filament and the hot box assays, respectively. In vitro, YHS exhibits prominent dopamine receptor antagonistic properties. In dopamine D2 receptor knockout mice, its antinociceptive effects are attenuated in acute and neuropathic pain but not inflammatory pain assays. Our results therefore indicate that YHS effectively attenuates acute, inflammatory and neuropathic pain, without causing tolerance. The effects on acute and neuropathic pain, but not inflammatory pain, are at least partially mediated through dopamine D2 receptor antagonism. Since YHS is a dietary supplement commercially available in the United States, our data suggest that it might be a candidate for alternative pain treatment.

Indexed as

CorydalisAcute PainAnalgesicsAnimalsDrugs, Chinese HerbalDrug ToleranceInflammationMaleMiceMice, 129 StrainMice, KnockoutNeuralgiaPain MeasurementReceptors, Dopamine D2AnalgesicsDRD2 protein, mouseDrugs, Chinese HerbalReceptors, Dopamine D2

Identifiers

PMID27622550
PMCPMC5021270
OpenAlexW2520480544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.